477 related articles for article (PubMed ID: 34836751)
1. SARS-CoV-2 infection and oxidative stress: Pathophysiological insight into thrombosis and therapeutic opportunities.
Alam MS; Czajkowsky DM
Cytokine Growth Factor Rev; 2022 Feb; 63():44-57. PubMed ID: 34836751
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
3. Mathematical Modeling of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Network with Cytokine Storm, Oxidative Stress, Thrombosis, Insulin Resistance, and Nitric Oxide Pathways.
Sasidharakurup H; Kumar G; Nair B; Diwakar S
OMICS; 2021 Dec; 25(12):770-781. PubMed ID: 34807729
[TBL] [Abstract][Full Text] [Related]
4. How to Restore Oxidative Balance That Was Disrupted by SARS-CoV-2 Infection.
Kiełbowski K; Herian M; Pawlik A
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742820
[TBL] [Abstract][Full Text] [Related]
5. Mixed storm in SARS-CoV-2 infection: A narrative review and new term in the Covid-19 era.
Alomair BM; Al-Kuraishy HM; Al-Gareeb AI; Al-Buhadily AK; Alexiou A; Papadakis M; Alshammari MA; Saad HM; Batiha GE
Immun Inflamm Dis; 2023 Apr; 11(4):e838. PubMed ID: 37102645
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus Disease 2019 and Stroke: Clinical Manifestations and Pathophysiological Insights.
Divani AA; Andalib S; Di Napoli M; Lattanzi S; Hussain MS; Biller J; McCullough LD; Azarpazhooh MR; Seletska A; Mayer SA; Torbey M
J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104941. PubMed ID: 32689643
[TBL] [Abstract][Full Text] [Related]
7. The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy.
Kouhpayeh S; Shariati L; Boshtam M; Rahimmanesh I; Mirian M; Esmaeili Y; Najaflu M; Khanahmad N; Zeinalian M; Trovato M; Tay FR; Khanahmad H; Makvandi P
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064039
[TBL] [Abstract][Full Text] [Related]
8. Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19.
Olwal CO; Nganyewo NN; Tapela K; Djomkam Zune AL; Owoicho O; Bediako Y; Duodu S
Front Immunol; 2021; 12():602848. PubMed ID: 33613574
[TBL] [Abstract][Full Text] [Related]
9. Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration.
Chen R; Lan Z; Ye J; Pang L; Liu Y; Wu W; Qin X; Guo Y; Zhang P
Front Immunol; 2021; 12():589095. PubMed ID: 33995341
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic application of estrogen for COVID-19: Attenuation of SARS-CoV-2 spike protein and IL-6 stimulated, ACE2-dependent NOX2 activation, ROS production and MCP-1 upregulation in endothelial cells.
Youn JY; Zhang Y; Wu Y; Cannesson M; Cai H
Redox Biol; 2021 Oct; 46():102099. PubMed ID: 34509916
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and COVID-19-associated neuronal dysfunction: mechanisms and therapeutic implications.
Bowen DR; Pathak S; Nadar RM; Parise RD; Ramesh S; Govindarajulu M; Moore A; Ren J; Moore T; Dhanasekaran M
Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(8):1153-1167. PubMed ID: 37357527
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality.
Al-Kuraishy HM; Al-Gareeb AI; Al-Hussaniy HA; Al-Harcan NAH; Alexiou A; Batiha GE
Int Immunopharmacol; 2022 Mar; 104():108516. PubMed ID: 35032828
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Induced Neurological Manifestations Entangles Cytokine Storm that Implicates for Therapeutic Strategies.
Chong ZZ; Souayah N
Curr Med Chem; 2022; 29(12):2051-2074. PubMed ID: 33970839
[TBL] [Abstract][Full Text] [Related]
14. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection.
Delgado-Roche L; Mesta F
Arch Med Res; 2020 Jul; 51(5):384-387. PubMed ID: 32402576
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets.
Fodor A; Tiperciuc B; Login C; Orasan OH; Lazar AL; Buchman C; Hanghicel P; Sitar-Taut A; Suharoschi R; Vulturar R; Cozma A
Oxid Med Cell Longev; 2021; 2021():8671713. PubMed ID: 34457119
[TBL] [Abstract][Full Text] [Related]
16. Host mitochondria: more than an organelle in SARS-CoV-2 infection.
Shoraka S; Samarasinghe AE; Ghaemi A; Mohebbi SR
Front Cell Infect Microbiol; 2023; 13():1228275. PubMed ID: 37692170
[TBL] [Abstract][Full Text] [Related]
17. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody therapy in COVID-19.
Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 Induces Cytokine Storm and Dysfunctional Hemostasis.
Charles J; Ploplis VA
Curr Drug Targets; 2022; 23(17):1603-1610. PubMed ID: 36284376
[TBL] [Abstract][Full Text] [Related]
20. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
